News|Articles|December 8, 2003

New Product Newswire

New Product Newswire for December 8, 2003 issue

 

NEW PRODUCT NEWSWIRE

Rx

NEW DRUGS

A new alpha-blocker has been launched in the United States by Sanofi-Synthelabo, New York City, (212) 551-4000. Uroxatral (alfuzosin hydrochloride extended-release tablets) is available in 10-mg strength for treatment of benign prostatic hyperplasia (BPH). The drug relaxes the muscle surrounding the prostate, bladder neck, and prostatic urethra for relief of BPH symptoms.

Internal server error